Philips and Polarean partner to bring advanced Xenon lung MRI to more children with chronic obstructive lung disease

"By integrating the Xenon MRI platform into our advanced 3.0T MRI systems, we're delivering a powerful, non-invasive tool that can transform how we diagnose, monitor, and manage chronic lung disease," said Dr. Ioannis Panagiotelis, Business Leader of MRI at Philips. "This radiation-free technology is especially important for younger patients and has the potential to shift multi-nuclei imaging from research to everyday clinical care. We're proud to be leading the way in making this innovation a routine part of clinical care."

"Using our FDA-cleared Polarean XENOVIEW 3T Chest Coil, clinicians can perform both Xenon and Proton scans during two 10-second breath-holds without needing to reposition the patient or switch coils. The procedure is intuitive via the Philips user interface and keeps total in-bore time to around one minute," said Dr. Christopher von Jako, Chief Executive Officer at Polarean. "Philips and Polarean share a common goal: to make lung imaging more precise, accessible, and patient-friendly. The introduction of the XENOVIEW 3T Chest Coil, combined with Philips' robust MRI platforms, marks a significant step in realizing that vision."